Aurora Cannabis achieves Australia’s TGA GMP certification

Aurora Cannabis received Good Manufacturing Practice GMP certification from Australia’s Therapeutic Goods Administration TGA for its Canadian production facilities, River and Ridge. The TGA is responsible for regulating the supply, import, export, manufacturing and advertising of therapeutic goods in Australia. Obtaining TGA’s GMP certification enables the company to deliver top-tier cannabis products to Australia while confirming Aurora’s dedication to exporting products fully compliant with TGA regulations and the stipulations of TGO 93 . The license grants approval for Aurora to broaden its product range offerings in the country, comprising dried flower, resin cartridges, pastilles and oils…This landmark certification, granted on March 15 strengthens Aurora’s dedication to supporting the continued growth and development of the Australian medical cannabis market, which is rapidly expanding and estimated to be worth $400M AUD, making it the largest medical market in the world outside of North America.1 As the long-standing exclusive supplier to MedReleaf Australia, and recently announced parent company, Aurora will continue to introduce innovative and differentiated products to the market.